Shelley Zieroth, Canada

MD, FCCS, FHFSA (hon), FESC, FACC, FHFA, FRCPC Cardiologist, St. Boniface Hospital Professor, University of Manitoba CCS Scientific Program Committee Chair (2021-2022) Winnipeg, Manitoba, Canada Dr. Shelley Zieroth joined the Section of Cardiology at St. Boniface Hospital in Winnipeg in July 2006. She is currently a Professor in the College of Medicine, Max Rady Faculty of Health Sciences, University of Manitoba, as well as Director of the Heart Failure and Heart Transplant Clinics. She is also Head of the Medical Heart Failure Program for Cardiac Sciences Manitoba. Dr. Zieroth attended medical school at the University of Manitoba and went on to train in Internal Medicine and Cardiology at the same centre. She completed her Postdoctoral Clinical Fellowship, specializing in Advanced Heart Failure and Cardiac Transplant, at Toronto General Hospital. She is involved in several heart failure clinical trials as a PI, National Lead or Executive Committee member. Her area of research examines the efficacy of new treatments including food derived bioactives, in heart failure. She is the Immediate Past President of the Canadian Heart Failure Society and on the Canadian Cardiovascular Society Primary Panels for both the Heart Failure and Heart Transplant Guidelines. She serves as Co-Chair of Canada’s largest annual heart failure meeting, HF Update and Scientific Planning Committee Chair for the Canadian Cardiovascular Congress hosted by the Canadian Cardiovascular Society. Her current passion is working with national and provincial patient advocacy groups and primary care to operationalize hub and spoke models of heart failure care. Dr. Zieroth is actively engaged in Social Media and promotes #cardiotwitter for its rapid access to clinical trial data, publications, and free online access to medical education. It is through this engagement Dr. Zieroth has become recognized as a global supporter and sponsor of women in medicine and cardiology.

Presenter of 2 Presentations

INDUSTRY SESSION

HF in T2D: perspectives from a diabetologist and a cardiologist

INDUSTRY SESSION

Welcome and Introduction

Moderator of 1 Session

INDUSTRY SESSION
Date
Fri, 04.06.2021
Session Type
INDUSTRY SESSION
Session Time
17:15 - 18:15
Room
Hall F
Session Description

Heart failure in Type 2 diabetes – early identification and intervention for improving patient outcome - Independent Medical Education Symposium supported by a unrestricted educational grant from AstraZeneca and Roche Diagnostics

Session description - Learning objectives:

This educational symposium will feature in-depth discussion around:

- The interconnectivity between T2D and HF

- The importance of interdisciplinary collaboration and early intervention in patients with T2D at risk of HF – the viewpoint of a diabetologist and a cardiologist

- The diagnostic role of NT-proBNP in HF in T2D

- The cardiorenal effects of SGLT2 inhibitors in patients with T2D with and without HF or CKD